Logo

American Heart Association

  7
  0


Final ID:

Con: Andexanet alfa is Preferred over PCC for Reversal of FXa Inhibitor Associated ICH

  • Yaghi, Shadi  ( Brown University , Providence , Rhode Island , United States )
  • Frontera, Jennifer  ( NYU Langone Hospitals , NYC , New York , United States )
  • Falcone, Guido  ( YALE UNIVERSITY SCHOOL OF MEDICINE , New Haven , Connecticut , United States )
  • Author Disclosures:
    Shadi Yaghi: DO NOT have relevant financial relationships | Jennifer Frontera: DO NOT have relevant financial relationships | Guido Falcone: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Fast and Furious: Stroke in the Real World - Addressing Challenges In Acute Stroke Management

Tuesday, 02/04/2025 , 08:30AM - 05:00PM

Pre-Con Symposium – Stroke in the Real World

More abstracts on this topic:
Hemorrhagic Stroke: What is the Goal and How Fast to get There?

Li Qi, Wang Xia

EVT for Mild severity or distal occlusion – what to do pending RCT

Goyal Mayank, Nogueira Raul, Leslie-mazwi Thabele, Nguyen Thanh, Fifi Johanna

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)